Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival

Sung W. Choi, Carrie L. Kitko, Thomas Braun, Sophie Paczesny, Gregory Yanik, Shin Mineishi, Oleg Krijanovski, Dawn Jones, Joel Whitfield, Kenneth Cooke, Raymond J. Hutchinson, James L.M. Ferrara, John E. Levine

Research output: Contribution to journalArticle

93 Scopus citations

Abstract

Acute graft-versus-host disease (GVHD) remains a significant cause of mortality after hematopoietic cell transplantation (HCT). Tumor necrosis factor-alpha (TNF-α) mediates GVHD by amplifying donor immune responses to host tissues and by direct toxicity to target organs.We measured TNF receptor 1 (TNFR1) as a surrogate marker for TNF-α in 438 recipients of myeloablative HCT before transplantation and at day 7 after transplantation. Increases in TNFR1 levels more than or equal to 2.5 baseline correlated with eventual development of GVHD grade 2 to 4 (58% vs 32%, P <.001) and with treatment-related mortality (39% vs 17%, P <.001). In a multivariate analysis including age, degree of HLA match, donor type, recipient and donor sex, disease, and status at HCT, the increase in TNFR1 level at day 7 remained a significant predictor for outcome. Measurement of TNFR1 levels early after transplantation provides independent information in advance of important clinical outcomes, such as GVHD and death.

Original languageEnglish (US)
Pages (from-to)1539-1542
Number of pages4
JournalBlood
Volume112
Issue number4
DOIs
StatePublished - Aug 15 2008

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival'. Together they form a unique fingerprint.

  • Cite this

    Choi, S. W., Kitko, C. L., Braun, T., Paczesny, S., Yanik, G., Mineishi, S., Krijanovski, O., Jones, D., Whitfield, J., Cooke, K., Hutchinson, R. J., Ferrara, J. L. M., & Levine, J. E. (2008). Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Blood, 112(4), 1539-1542. https://doi.org/10.1182/blood-2008-02-138867